These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34961464)

  • 1. Comprehensive Review on Neuro-degenerative Type 3 DM.
    Chandarana CV; Roy S
    Curr Diabetes Rev; 2022; 18(8):e131221198790. PubMed ID: 34961464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
    Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
    J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
    de la Monte SM
    Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes.
    Michailidis M; Moraitou D; Tata DA; Kalinderi K; Papamitsou T; Papaliagkas V
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 3 Diabetes and Its Role Implications in Alzheimer's Disease.
    Nguyen TT; Ta QTH; Nguyen TKO; Nguyen TTD; Giau VV
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.
    Zhao WQ; Townsend M
    Biochim Biophys Acta; 2009 May; 1792(5):482-96. PubMed ID: 19026743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron metabolism in diabetes-induced Alzheimer's disease: a focus on insulin resistance in the brain.
    Chung JY; Kim HS; Song J
    Biometals; 2018 Oct; 31(5):705-714. PubMed ID: 30043289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
    Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-Wide Insulin Resistance, Tau Phosphorylation Changes, and Hippocampal Neprilysin and Amyloid-β Alterations in a Monkey Model of Type 1 Diabetes.
    Morales-Corraliza J; Wong H; Mazzella MJ; Che S; Lee SH; Petkova E; Wagner JD; Hemby SE; Ginsberg SD; Mathews PM
    J Neurosci; 2016 Apr; 36(15):4248-58. PubMed ID: 27076423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal Molecular Interactions between the Aβ Peptide Linked to Alzheimer's Disease and Insulin Linked to Diabetes Mellitus Type II.
    Luo J; Wärmländer SK; Gräslund A; Abrahams JP
    ACS Chem Neurosci; 2016 Mar; 7(3):269-74. PubMed ID: 26785771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets.
    Hamzé R; Delangre E; Tolu S; Moreau M; Janel N; Bailbé D; Movassat J
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut dysbiosis, insulin resistance and Alzheimer's disease: review of a novel approach to neurodegeneration.
    Lazar E; Sherzai A; Adeghate J; Sherzai D
    Front Biosci (Schol Ed); 2021 Jun; 13(1):17-29. PubMed ID: 34256527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.
    Kimura N
    Int J Mol Sci; 2016 Apr; 17(4):503. PubMed ID: 27058526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.
    Qiu WQ; Folstein MF
    Neurobiol Aging; 2006 Feb; 27(2):190-8. PubMed ID: 16399206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crucial players in Alzheimer's disease and diabetes mellitus: Friends or foes?
    Kubis-Kubiak AM; Rorbach-Dolata A; Piwowar A
    Mech Ageing Dev; 2019 Jul; 181():7-21. PubMed ID: 31085195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPK: A bridge between diabetes mellitus and Alzheimer's disease.
    Chen M; Huang N; Liu J; Huang J; Shi J; Jin F
    Behav Brain Res; 2021 Feb; 400():113043. PubMed ID: 33307136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
    Zhao Z; Ho L; Wang J; Qin W; Festa ED; Mobbs C; Hof P; Rocher A; Masur S; Haroutunian V; Pasinetti GM
    FASEB J; 2005 Dec; 19(14):2081-2. PubMed ID: 16186174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.